Election Day could produce massive changes in Washington and in the policies that would affect every American and every company. Even a status quo election could produce lasting regulatory consequences for key stakeholders....more
10/30/2020
/ Climate Change ,
Corporate Governance ,
Donald Trump ,
Federal Budget ,
Filibuster ,
Financial Services Industry ,
Financial Stimulus ,
Joe Biden ,
Political Campaigns ,
Political Candidates ,
Presidential Elections ,
Public Policy ,
Tax Reform ,
Trump Administration
The Senate is beginning to draft what likely will be the largest emergency relief and fiscal stimulus legislation in the country’s history – more than $1 trillion – to address the mushrooming coronavirus pandemic....more
1. 2020: More of the same or next-level craziness?
Despite a series of near-cataclysmic political events throughout 2019 – from the longest government shutdown in U.S. history and the release of special counsel Robert...more
HEALTH PROVISIONS FACE UNCERTAINTY AS CONGRESS RETURNS FOR BUSY DECEMBER -
Lawmakers return to Washington this week after the Thanksgiving holiday with only 18 days before the government runs out of money – and that’s not...more
FDA NOMINATION HEARING DRIVES THE WEEK IN HEALTH POLICY -
President Trump’s nominee to lead the Food and Drug Administration, Dr. Stephen Hahn, will appear Wednesday before the Senate Health, Education, Labor and Pensions...more
COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES -
House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the...more
DEMOCRATS PRESS FOR PRE-THANKSGIVING VOTE ON DRUG PRICING BILL -
The House Ways and Means Committee last week approved an amended version of legislation that would overhaul how Medicare and private insurers reimburse for...more
PELOSI INTRODUCES DRUG PRICING BILL WHILE TRUMP PUSHES SENATE VERSION -
House Democrats introduced legislation last week to lower prescription drug prices – including allowing Medicare to negotiate prices with...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
TRUMP, DEMOCRATIC LEADERS TO MEET ON DRUG PRICES -
During a White House meeting last week on infrastructure...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: shutdown risk increases as talks stall; Gottlieb’s Hill testimony postponed; more bills...more
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more
2/5/2019
/ Affordable Care Act ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Medical Devices ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Pharmaceutical Industry ,
Preexisting Conditions ,
Prescription Drugs ,
Trump Administration
Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves Medicaid measures, and more....more
Fresh-from-the-campaign idealism will collide with old-fashioned partisanship on Capitol Hill today as more than 100 first-time lawmakers are sworn in and the 116th Congress is gaveled into session....more
Highlights this week include a lame duck update on year-end health bills and tax provisions; lawmakers reacting to a federal judge ruling the Affordable Care Act is unconstitutional; Sen. Hatch seeks to update Hatch-Waxman;...more
12/17/2018
/ Affordable Care Act ,
Congressional Budget Office ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Furloughs ,
Government Shutdown ,
Medicare Part D ,
Patents ,
Pharmaceutical Industry ,
Trump Administration ,
USPTO
Highlights this week: Lawmakers renew efforts to avoid a partial government shutdown, which would affect FDA; key senators introduce legislation on Medicaid prescription drug rebates; the House votes this week on allowing...more
Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key...more
When Republicans muscled the Tax Cut and Jobs Act through Congress in late 2017, all Democrats could do was howl from the sidelines. Procedurally, Republicans didn’t need Democrats’ support to approve the sweeping tax...more
Democrats’ slender majority in the House next year will have an outsized impact on healthcare policy and healthcare stakeholders in 2019 and beyond. From potential bipartisan deals on prescription drug prices to Democrats’...more
Democrats capitalized on President Donald Trump’s unpopularity in suburban districts to capture the House majority, but the president helped turn out Republican voters in states he won two years ago to add to the GOP’s Senate...more
The Trump administration announced Sunday night that trade ministers from the United States, Mexico and Canada had reached agreement on revisions to the 1994 North American Free Trade Agreement, the framework for $1.2...more
The House on Wednesday gave final congressional approval to a fiscal 2019 spending bill covering 70 percent of the government’s discretionary operations, and President Donald Trump said he would sign it into law – temporarily...more
House and Senate leaders Wednesday agreed to sweeping new legislation to respond to the national opioid epidemic, including authorizing $8 billion in grant programs for states, expanding access to prevention and treatment,...more
Absent an unpredictable event at the Senate Judiciary Committee hearing Thursday, Republicans intend to move quickly to advance Brett Kavanaugh’s nomination to the Supreme Court....more